These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Author: Bondarenko IP, Dubinskiĭ AA, Tereshkin IG.
    Journal: Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578.
    Abstract:
    The possibility was studied of using the native beta-adrenoblocking agent anaprilin for prolonged control of the level of portal hypertension in liver cirrhosis. It was established that anaprilin (dose: 40 mg daily) reduces the level of portal hypertension and increases the efficacy of treatment of liver cirrhosis associated with ascites and esophageal-gastric bleeding. A therapeutic effect was achieved in most patients (67 of 75).
    [Abstract] [Full Text] [Related] [New Search]